Hans Schlößer

4.1k total citations · 1 hit paper
65 papers, 2.6k citations indexed

About

Hans Schlößer is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Hans Schlößer has authored 65 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 20 papers in Immunology and 13 papers in Surgery. Recurrent topics in Hans Schlößer's work include Cancer Immunotherapy and Biomarkers (19 papers), Immune Cell Function and Interaction (11 papers) and Esophageal Cancer Research and Treatment (10 papers). Hans Schlößer is often cited by papers focused on Cancer Immunotherapy and Biomarkers (19 papers), Immune Cell Function and Interaction (11 papers) and Esophageal Cancer Research and Treatment (10 papers). Hans Schlößer collaborates with scholars based in Germany, United States and Singapore. Hans Schlößer's co-authors include Alexander Shimabukuro‐Vornhagen, Michael S. von Bergwelt‐Baildon, Philipp Gödel, Max Schlaak, Marion Subklewe, Matthias Kochanek, Boris Böll, Hans‐Joachim Stemmler, Kerstin Wennhold and Michael von Bergwelt‐Baildon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Langmuir.

In The Last Decade

Hans Schlößer

58 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokine release syndrome

2018 1.2k citations Alexander Shimabukuro‐Vornhagen, Hans Schlößer et al. profile →

Peers

Countries citing papers authored by Hans Schlößer

Since Specialization

Citations

This map shows the geographic impact of Hans Schlößer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Schlößer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Schlößer more than expected).

Fields of papers citing papers by Hans Schlößer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Schlößer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Schlößer. The network helps show where Hans Schlößer may publish in the future.

Co-authorship network of co-authors of Hans Schlößer

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Schlößer. A scholar is included among the top collaborators of Hans Schlößer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Schlößer. Hans Schlößer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD‐1 Inhibition as Potential Treatment Option 2025 ·Mycoses ·Sibylle C. Mellinghoff, Martin Thelen, Michael von Bergwelt‐Baildon, Hans Schlößer, Oliver A. Cornely, Rosanne Sprute, Jannik Stemler, Leonie Mayer, (unknown), (unknown), My Linh Ly, Christine Dahlke, Marylyn M. Addo	2
2	Hybrid immunity to SARS‐CoV ‐2 in patients with chronic lymphocytic leukemia 2024 ·European Journal Of Haematology ·Sibylle C. Mellinghoff, Sandra Robrecht, Rosanne Sprute, Leonie Mayer, (unknown), Christine Dahlke, Henning Gruell, (unknown), Hans Schlößer, (unknown), Martin Thelen, Anna‐Maria Fink, Kirsten Fischer, Florian Klein, Marylyn M. Addo, Androniki Kolovou, Oliver A. Cornely, Barbara Eichhorst, Michael Hallek, Petra Langerbeins	0
3	Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer 2024 ·Radiation Oncology ·Simone Wegen, (unknown), (unknown), Johannes Rosenbrock, Maike Trommer, Thomas Zander, Armin Tuchscherer, Christiane J. Bruns, Hans Schlößer, Wolfgang Schröder, Marie‐Lisa Eich, Thomas Fischer, Klaus Schomäcker, Alexander Drzezga, Carsten Kobe, (unknown), (unknown)	7
4	Correlation of primary tumor volume and histopathologic response following neoadjuvant treatment of esophageal adenocarcinoma 2024 ·European Journal of Surgical Oncology ·(unknown), Stefanie Brunner, Erkan Çelik, Alexander Damanakis, Hans Schlößer, Hans F. Fuchs, Thomas Schmidt, Thomas Zander, David Maintz, Christiane J. Bruns, Alexander Quaas, Daniel Pinto dos Santos, Wolfgang Schroeder	2
5	T-cell diversity and exclusion of blood-derived T-cells in the tumor microenvironment of classical Hodgkin Lymphoma 2024 ·Leukemia ·Nicole Seifert, Sarah Reinke, (unknown), (unknown), Julia Richter, (unknown), Hans Schlößer, Michaela Kotrová, Monika Brüggemann, Peter Borchmann, Paul J. Bröckelmann, Michael Altenbuchinger, Wolfram Klapper	1
6	Serum TARC Dynamics Correlate with Clinical Response and Metabolic Tumor Volume during Anti-PD1-Based First-Line HL Treatment in the GHSG Phase II Nivahl Trial 2024 ·Blood ·Paul J. Bröckelmann, (unknown), Lydia Visser, Conrad‐Amadeus Voltin, (unknown), Hans Schlößer, Bart‐Jan Kroesen, Carsten Kobe, Peter Borchmann, Arjan Diepstra, Wouter J. Plattel	1
7	Combined regression score predicts outcome after neoadjuvant treatment of oesophageal cancer 2023 ·British Journal of Cancer ·Alexander Damanakis, Florian Gebauer, (unknown), Hans Schlößer, Markus P. Ghadimi, Thomas Schmidt, Lars M. Schiffmann, Hans F. Fuchs, Thomas Zander, Alexander Quaas, Christiane J. Bruns, Wolfgang Schroeder	4
8	Low B‐cell content is associated with a CD73‐low tumour microenvironment and unfavourable prognosis in classic Hodgkin lymphoma 2023 ·British Journal of Haematology ·(unknown), (unknown), Sarah Reinke, (unknown), Annette Plütschow, (unknown), (unknown), Hans Schlößer, Bastian von Tresckow, Fabian Kellermeier, Peter Borchmann, Andreas Engert, Paul J. Bröckelmann, Wolfram Klapper	6
9	TIGIT+ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients 2023 ·BMC Cancer ·Anastasia Tsakmaklis, Fedja Farowski, (unknown), Till Robin Lesker, Till Strowig, Hans Schlößer, (unknown), Michael von Bergwelt‐Baildon, Cornelia Mauch, Max Schlaak, Jana Knuever, (unknown), Lucie Heinzerling, Maria J. G. T. Vehreschild	8
10	CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses 2021 ·Cancer Immunology Research ·Kerstin Wennhold, Martin Thelen, (unknown), (unknown), (unknown), María A. García-Márquez, Axel Lechner, Alexander Shimabukuro‐Vornhagen, Meryem S. Ercanoglu, Florian Klein, Fabinshy Thangarajah, Sebastian Eidt, Heike Löser, Christiane J. Bruns, Alexander Quaas, Michael von Bergwelt‐Baildon, Hans Schlößer	65
11	Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus 2021 ·Clinical & Translational Oncology ·(unknown), (unknown), (unknown), Svenja Wagener‐Ryczek, Axel M. Hillmer, Christiane J. Bruns, Martin Thelen, Wolfgang Schröder, Thomas Zander, Axel Lechner, Reinhard Buettner, Hans Schlößer, Florian Gebauer, Alexander Quaas, (unknown), (unknown), (unknown)	8
12	Hand-Assisted Retroperitoneoscopic Donor Nephrectomy Compared to Anterior Approach Open Donor Nephrectomy: Improved Long-Term Physical Component Score in Health-Related Quality of Life in Living Kidney Donors 2020 ·Transplantation Proceedings ·Roger Wahba, Frank Vitinius, (unknown), (unknown), Denise Buchner, Rabi R. Datta, (unknown), Hans Schlößer, Michael Thomas, Roman Ulrich Müller, Martin Kann, Martin Hellmich, Christine Kurschat, Dirk L. Stippel	3
13	Tumor biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers 2019 ·Seminars in Cancer Biology ·Yue Zhao, Jiahui Li, Dai Li, Zhefang Wang, Jiangang Zhao, Xiaolin Wu, (unknown), Peter Ping Lin, Patrick Sven Plum, Alexander Damanakis, Florian Gebauer, Menglong Zhou, Zhen Zhang, Hans Schlößer, Karl-Walter Jauch, Peter J. Nelson, Christiane J. Bruns	34
14	Using Antigen-Specific B Cells to Combine Antibody and T Cell–Based Cancer Immunotherapy 2017 ·Cancer Immunology Research ·Kerstin Wennhold, Martin Thelen, Hans Schlößer, (unknown), (unknown), María A. García-Márquez, Axel Lechner, Sebastian Kobold, Felicitas Rataj, Olaf Utermöhlen, Geothy Chakupurakal, Sebastian Theurich, Michael Hallek, Hinrich Abken, Alexander Shimabukuro‐Vornhagen, Michael von Bergwelt‐Baildon	28
15	Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma 2015 ·Annals of Surgical Oncology ·Felix Berlth, Stefan Mönig, (unknown), Peter Grimminger, Martin Maus, Hans Schlößer, Patrick Sven Plum, Ute Warnecke‐Eberz, Olivier Harismendy, Uta Drebber, Elfriede Bollschweiler, A. H. Hölscher, Hakan Alakus	30
16	Herrschaftliches Strafen seit dem Hochmittelalter : Formen und Entwicklungsstufen 2002 ·Böhlau eBooks ·Hans Schlößer, (unknown), (unknown)	1
17	Grundzüge der neueren Privatrechtsgeschichte : Rechtsentwicklungen im europäischen Kontext 2001 ·C.F. Müller eBooks ·Hans Schlößer	0
18	Neue Wege strafrechtsgeschichtlicher Forschung 1999 ·OPUS (Augsburg University) ·Hans Schlößer, (unknown)	3
19	Die ambulante Hystero-Kontrast-Sonographie (HKSG) als Möglichkeit zur Kontrolle der Tubendurchgängigkeit 1995 ·Geburtshilfe und Frauenheilkunde ·(unknown), (unknown), (unknown), (unknown), Hans Schlößer	6
20	Spätmittelalterlicher Zivilprozess nach bayerischen Quellen : Gerichtsverfassung und Rechtsgang 1971 ·Böhlau eBooks ·Hans Schlößer	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact